Effect of in vitro Mutations in a Vaccinia Virus Early Promoter Region Monitored by Herpes Simplex Virus Thymidine Kinase Expression in Recombinant Vaccinia Virus
- 1 September 1987
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 68 (9) , 2299-2309
- https://doi.org/10.1099/0022-1317-68-9-2299
Abstract
The location of a promoter (PF) in the HindIII F region of the vaccinia virus genome was mapped by introducing deletions into this region of the DNA. Modified promoters were fused to the herpes simplex virus (HSV) thymidine kinase (TK) gene in plasmids facilitating the construction of recombinant vaccinia viruses, and promoter function was monitored by the ability of such plasmids to rescue TK+ vaccinia viruses from cells infected with TK- virus. Deletions from the 3'' end of the promoter region produced mutants for which function was either not inhibited or abolished, allowing the 3'' promoter boundary to be defined to within 13 nucleotides. As indicated by the presence of the PF transcript in early RNA and the kinetics of HSV TK expression in recombinant vaccinia viruses, transcription from PF occurred primarily at early times during infection. The major transcript was initiated at a site within 20 nucleotides of the 3'' end of the promoter and nine bases upstream of the probable translation initiation codon. In one mutant for which a small but reproducible increase in promoter function was detected, the transcription start site was deleted. Nevertheless, transcription still appeared to begin at the equivalent position with respect to the promoter, despite the altered nucleotide sequence. The location of the start site for the PF transcript indicated that the HSV TK gene, inserted at the BamHI site following the promoter, was preceded by an initiation codon which could potentially attenuate expression of the inserted gene. Conversion of this ATG codon to TAG did not significantly improve HSV TK expression.This publication has 20 references indexed in Scilit:
- Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.Proceedings of the National Academy of Sciences, 1983
- Nucleotide sequence of the vaccinia virus thymidine kinase gene and the nature of spontaneous frameshift mutationsJournal of Virology, 1983
- Vaccinia virus: a selectable eukaryotic cloning and expression vector.Proceedings of the National Academy of Sciences, 1982
- The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primersGene, 1982
- Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.Proceedings of the National Academy of Sciences, 1982
- Molecular genetics of vaccinia virus: demonstration of marker rescue.Proceedings of the National Academy of Sciences, 1982
- Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNAProceedings of the National Academy of Sciences, 1982
- Nucleotide sequence of the thymidine kinase gene of herpes simplex virus type 1.Proceedings of the National Academy of Sciences, 1981
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977
- A new method for sequencing DNA.Proceedings of the National Academy of Sciences, 1977